Literature DB >> 16500306

Cellular basis for electrocardiographic and arrhythmic manifestations of Andersen-Tawil syndrome (LQT7).

Masato Tsuboi1, Charles Antzelevitch.   

Abstract

BACKGROUND: Andersen-Tawil syndrome, a skeletal muscle syndrome associated with periodic paralysis and long QT intervals on the ECG, has been linked to defects in KCNJ2, the gene encoding for the inward rectifier potassium channel (I(K1).)
OBJECTIVES: The purpose of this study was to examine the cellular mechanisms underlying the ECG and arrhythmic manifestations of Andersen-Tawil syndrome.
METHODS: To investigate the effects of KCNJ2 loss-of-function mutations responsible for Andersen-Tawil syndrome, we used barium chloride (BaCl(2)) to inhibit I(K1) in arterially perfused wedge preparation. Transmembrane action potentials (APs) were simultaneously recorded from endocardial, midmyocardial, and epicardial cells, together with a transmural ECG.
RESULTS: BaCl(2) (1 to 30 microM) produced a concentration-dependent prolongation of the QT interval, secondary to a homogeneous prolongation of AP duration of the three cell types. QT interval was prolonged without an increase in transmural dispersion of repolarization (TDR). Low extracellular potassium (2.0 mM), isoproterenol (20-50 nM), and an abrupt increase in temperature (36 degrees C-39 degrees C) in the presence of 10 microM BaCl(2) did not significantly increase TDR but increased ectopic extrasystolic activity. Early afterdepolarizations were not observed under any condition. Spontaneous torsades de pointes arrhythmias were never observed, nor could they be induced with programmed electrical stimulation under any of the conditions studied.
CONCLUSION: Our results provide an understanding of why QT prolongation associated with Andersen-Tawil syndrome is relatively benign in the clinic and provide further support for the hypothesis that the increase in TDR, rather than QT interval, is responsible for development of torsades de pointes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16500306      PMCID: PMC1474110          DOI: 10.1016/j.hrthm.2005.11.026

Source DB:  PubMed          Journal:  Heart Rhythm        ISSN: 1547-5271            Impact factor:   6.343


  25 in total

1.  Functional role of inward rectifier current in heart probed by Kir2.1 overexpression and dominant-negative suppression.

Authors:  Junichiro Miake; Eduardo Marbán; H Bradley Nuss
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Function, subcellular localization and assembly of a novel mutation of KCNJ2 in Andersen's syndrome.

Authors:  Yukio Hosaka; Haruo Hanawa; Takashi Washizuka; Masaomi Chinushi; Fumio Yamashita; Tsuyoshi Yoshida; Satoru Komura; Hiroshi Watanabe; Yoshifusa Aizawa
Journal:  J Mol Cell Cardiol       Date:  2003-04       Impact factor: 5.000

3.  Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome?

Authors:  E D Andersen; P A Krasilnikoff; H Overvad
Journal:  Acta Paediatr Scand       Date:  1971-09

4.  Novel KCNJ2 mutation in familial periodic paralysis with ventricular dysrhythmia.

Authors:  Tomohiko Ai; Yuichiro Fujiwara; Keiko Tsuji; Hideo Otani; Shozo Nakano; Yoshihiro Kubo; Minoru Horie
Journal:  Circulation       Date:  2002-06-04       Impact factor: 29.690

5.  PIP2 binding residues of Kir2.1 are common targets of mutations causing Andersen syndrome.

Authors:  M R Donaldson; J L Jensen; M Tristani-Firouzi; R Tawil; S Bendahhou; W A Suarez; A M Cobo; J J Poza; E Behr; J Wagstaff; P Szepetowski; S Pereira; T Mozaffar; D M Escolar; Y-H Fu; L J Ptácek
Journal:  Neurology       Date:  2003-06-10       Impact factor: 9.910

6.  Functional and clinical characterization of KCNJ2 mutations associated with LQT7 (Andersen syndrome).

Authors:  Martin Tristani-Firouzi; Judy L Jensen; Matthew R Donaldson; Valeria Sansone; Giovanni Meola; Angelika Hahn; Said Bendahhou; Hubert Kwiecinski; Anna Fidzianska; Nikki Plaster; Ying-Hui Fu; Louis J Ptacek; Rabi Tawil
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

7.  KCNJ2 mutation results in Andersen syndrome with sex-specific cardiac and skeletal muscle phenotypes.

Authors:  Gregor Andelfinger; Andrew R Tapper; Richard C Welch; Carlos G Vanoye; Alfred L George; D Woodrow Benson
Journal:  Am J Hum Genet       Date:  2002-07-29       Impact factor: 11.025

8.  Barium-induced blockade of the inward rectifier in calf Purkinje fibres.

Authors:  D DiFrancesco; A Ferroni; S Visentin
Journal:  Pflugers Arch       Date:  1984-12       Impact factor: 3.657

9.  Differential effects of beta-blockade on dispersion of repolarization in the absence and presence of sympathetic stimulation between the LQT1 and LQT2 forms of congenital long QT syndrome.

Authors:  Wataru Shimizu; Yasuko Tanabe; Takeshi Aiba; Masashi Inagaki; Takashi Kurita; Kazuhiro Suyama; Noritoshi Nagaya; Atsushi Taguchi; Naohiko Aihara; Kenji Sunagawa; Kazufumi Nakamura; Tohru Ohe; Jeffrey A Towbin; Silvia G Priori; Shiro Kamakura
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

10.  Andersen mutations of KCNJ2 suppress the native inward rectifier current IK1 in a dominant-negative fashion.

Authors:  Philipp S Lange; Fikret Er; Natig Gassanov; Uta C Hoppe
Journal:  Cardiovasc Res       Date:  2003-08-01       Impact factor: 10.787

View more
  26 in total

1.  IK1 and cardiac hypoxia: after the long and short QT syndromes, what else can go wrong with the inward rectifier K+ currents?

Authors:  Yanfang Xu; Qian Zhang; Nipavan Chiamvimonvat
Journal:  J Mol Cell Cardiol       Date:  2007-04-29       Impact factor: 5.000

Review 2.  Drug-induced spatial dispersion of repolarization.

Authors:  Charles Antzelevitch
Journal:  Cardiol J       Date:  2008       Impact factor: 2.737

3.  Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.

Authors:  Amanda L Vega; David J Tester; Michael J Ackerman; Jonathan C Makielski
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-08-25

4.  Deciphering Arrhythmia Mechanisms - Tools of the Trade.

Authors:  Guy Salama; Fadi G Akar
Journal:  Card Electrophysiol Clin       Date:  2011-03

Review 5.  Ionic, molecular, and cellular bases of QT-interval prolongation and torsade de pointes.

Authors:  Charles Antzelevitch
Journal:  Europace       Date:  2007-09       Impact factor: 5.214

6.  Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.

Authors:  Jessica Manning; Pattaraporn Vanachayangkul; Chanthap Lon; Michele Spring; Mary So; Darapiseth Sea; Youry Se; Sok Somethy; Sut-Thang Phann; Soklyda Chann; Sabaithip Sriwichai; Nillawan Buathong; Worachet Kuntawunginn; Mashamon Mitprasat; Raveewan Siripokasupkul; Paktiya Teja-Isavadharm; Eugene Soh; Ans Timmermans; Charlotte Lanteri; Jaranit Kaewkungwal; Montida Auayporn; Douglas Tang; Char Meng Chour; Satharath Prom; Mark Haigney; Louis Cantilena; David Saunders
Journal:  Antimicrob Agents Chemother       Date:  2014-08-04       Impact factor: 5.191

7.  Novel mutation in the KCNJ2 gene is associated with a malignant arrhythmic phenotype of Andersen-Tawil syndrome.

Authors:  E Fernlund; C Lundin; E Hertervig; O Kongstad; M Alders; P Platonov
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09       Impact factor: 1.468

8.  Transseptal dispersion of repolarization and its role in the development of Torsade de Pointes arrhythmias.

Authors:  Serge Sicouri; Aaron Glass; Marcela Ferreiro; Charles Antzelevitch
Journal:  J Cardiovasc Electrophysiol       Date:  2009-11-10

9.  Risk stratification in young patients with channelopathies.

Authors:  N Sreeram; U Trieschmann; M Khalil; M Emmel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

10.  Ventricular ectopy during REM sleep: implications for nocturnal sudden cardiac death.

Authors:  Arturo Garcia-Touchard; Virend K Somers; Tomas Kara; Jiri Nykodym; Abu Shamsuzzaman; Paola Lanfranchi; Michael J Ackerman
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.